Publications by authors named "Omar H Butt"

Claim this Profile
D
Daily locomotor activity declines with tumor growth and disease progression in glioblastoma.
Maria F Gonzalez-Aponte, Sofia V Salvatore, Anna R Damato, Ruth Gn Katumba, Grayson R Talcott, Omar H Butt

JCI Insight· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circadian variation in MGMT promoter methylation and expression predicts sensitivity to temozolomide in glioblastoma.
Maria F Gonzalez-Aponte, Yitong Huang, William A Leidig, Tatiana Simon, Omar H Butt

J Neurooncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tracking Daily Variations in Rest-Wake to Guide Personalized Timing of Temozolomide for High-Grade Glioma Patients.
Maria F Gonzalez-Aponte, Anna R Damato, Ruth G N Katumba, Grayson R Talcott, Jian L Campian, Omar H Butt

J Biol Rhythms· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circadian variation in MGMT promoter methylation and expression predicts sensitivity to Temozolomide in glioblastoma.
Maria F Gonzalez-Aponte, Yitong Huang, William A Leidig, Tatiana Simon, Omar H Butt

Res Sq· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sociodemographic factors predict outcomes and reveal spatial tumor patterns in glioblastoma.
Patrick H Luckett, Michael Olufawo, Noah Naddaff-Slocum, Ki Yun Park, Bidhan Lamichhane, Omar H Butt

Neurooncol Adv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting post-surgical functional status in high-grade glioma with resting state fMRI and machine learning.
Patrick H Luckett, Michael O Olufawo, Ki Yun Park, Bidhan Lamichhane, Donna Dierker, Omar H Butt

J Neurooncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poly (ADP-Ribose) Polymerase inhibitors (PARPi) therapy response in an acral melanoma patient with EMSY gene amplification.
George Nassief, Omar H Butt, Alice Y Zhou, George Ansstas

JAAD Case Rep· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving Barriers to Clinical Trial Enrollment and Clinical Care in Neuro-oncology in the Face of COVID-19.
Nikhil Grandhi, Alice Y Zhou, Margaret O Johnson, Omar H Butt

Semin Neurol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PARP inhibition and immunotherapy: a promising duo in fighting cancer.
Jordan Phillipps, Alice Y Zhou, Omar H Butt, George Ansstas

Transl Cancer Res· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic clusters underlie heterogeneity in preclinical Alzheimer's disease progression.
Julie K Wisch, Omar H Butt, Brian A Gordon, Suzanne E Schindler, Anne M Fagan

Brain· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gut microbiome composition may be an indicator of preclinical Alzheimer's disease.
Aura L Ferreiro, JooHee Choi, Jian Ryou, Erin P Newcomer, Regina Thompson, Omar H Butt

Sci Transl Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homologous Recombination Deficiency (HRD) in Cutaneous Oncology.
Favour A Akinjiyan, Renee Morecroft, Jordan Phillipps, Tolulope Adeyelu, Andrew Elliott, Omar H Butt

Int J Mol Sci· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma proteomics of SARS-CoV-2 infection and severity reveals impact on Alzheimer's and coronary disease pathways.
Lihua Wang, Daniel Western, Jigyasha Timsina, Charlie Repaci, Won-Min Song, Omar H Butt

iScience· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic framework for predictive biomarkers in immune effector cell-associated neurotoxicity syndrome.
Omar H Butt, Alice Y Zhou, Beau M Ances, John F DiPersio, Armin Ghobadi

Front Neurol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study.
Anna H Boerwinkle, Brian A Gordon, Julie Wisch, Shaney Flores, Rachel L Henson, Omar H Butt

Lancet Neurol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Identification and management of aggressive meningiomas.
Bhuvic Patel, Rupen Desai, Sangami Pugazenthi, Omar H Butt, Jiayi Huang

Front Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Pretreatment and Posttreatment Evolution of Neurofilament Light Chain Levels in Patients Who Develop Immune Effector Cell-Associated Neurotoxicity Syndrome.
Omar H Butt, Alice Y Zhou, Paolo F Caimi, Patrick H Luckett, Julie K Wisch

JAMA Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: Real-world experience using a personalized cancer-specific circulating tumor DNA assay in different metastatic melanoma scenarios.
Karam Khaddour, Alice Zhou, Omar H Butt, Griffin Budde, Allyson Koyen Malashevich

Front Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma proteomics of SARS-CoV-2 infection and severity reveals impact on Alzheimer and coronary disease pathways.
Lihua Wang, Dan Western, Jigyasha Timsina, Charlie Repaci, Won-Min Song, Omar H Butt

medRxiv· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebrospinal fluid neurofilament light chain is a marker of aging and white matter damage.
Karin L Meeker, Omar H Butt, Brian A Gordon, Anne M Fagan, Suzanne E Schindler

Neurobiol Dis· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized feasibility study evaluating temozolomide circadian medicine in patients with glioma.
Anna R Damato, Ruth G N Katumba, Jingqin Luo, Himachandana Atluri, Grayson R Talcott, Omar H Butt

Neurooncol Pract· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to: A phase II study of laser interstitial thermal therapy combined with doxorubicin in patients with recurrent glioblastoma.
Omar H Butt, Alice Y Zhou, Jiayi Huang, William A Leidig, Alice E Silberstein

Neurooncol Adv· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged response of recurrent -wild-type glioblastoma to laser interstitial thermal therapy with pembrolizumab.
Helen Hwang, Jiayi Huang, Karam Khaddour, Omar H Butt, George Ansstas

CNS Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and Management of Aggressive Meningiomas.
Bhuvic Patel, Rupen Desai, Sangami Pugazenthi, Omar H Butt, Jiayi Huang

Front Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of laser interstitial thermal therapy combined with doxorubicin in patients with recurrent glioblastoma.
Omar H Butt, Alice Y Zhou, Jiayi Huang, William A Leidig, Alice E Silberstein

Neurooncol Adv· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis